Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Kaleyra Q4 EPS $(0.10), Sales $93.70M

Kaleyra Q4 EPS $(0.10), Sales $93.70M

Kaleyra (NYSE:KLR) reported quarterly losses of $(0.10) per share. The company reported $93.70 million in sales this quarter.

byHappy Mohamed

February 15, 2023

1 minute read

Kaleyra (NYSE:KLR) reported quarterly losses of $(0.10) per share. The company reported $93.70 million in sales this quarter.

Morgan Stanley Maintains Equal-Weight on Bread Financial Holdings, Lowers Price Target to $45

By Benzinga Newsdesk

July 12, 8:49 AM

Morgan Stanley analyst Betsy Graseck maintains Bread Financial Holdings (NYSE:BFH) with a Equal-Weight and lowers the price target from $67 to $45.

BFH

EA SPORTS And CONMEBOL Strengthen Their Commitment To Football With Multi-Year Partnership Renewal

By Happy Mohamed

June 7, 11:28 AM

The multi-year partnership renewal sees EA SPORTS continue as CONMEBOL's exclusive Sports Video Gaming Partner, and will include additional support of grassroots football initiatives and sponsorship of CONMEBOL Club

Earnings

Looking Into Hayward Holdings’s Return On Invested Capital

By Benzinga Insights

May 15, 10:46 AM

According to Benzinga Pro, during Q1, Hayward Holdings (NYSE:HAYW) earned $8.41 million, a 47.33% increase from the preceding…

HAYW

Pfizer, Valneva’s Tick-Borne Infection Shot: Companies Say ‘Positive’ Result For Lyme Disease Vaccine Candidate Booster

By Vandana Singh

September 7, 7:32 AM

Valneva SE (NASDAQ: VALN) and Pfizer Inc (NYSE: PFE) released pediatric and adolescent immunogenicity and safety data for their Lyme disease vaccine candidate,

PFE

Kaleyra Q4 EPS $(0.10), Sales $93.70M

Related Posts

Morgan Stanley Maintains Equal-Weight on Bread Financial Holdings, Lowers Price Target to $45

EA SPORTS And CONMEBOL Strengthen Their Commitment To Football With Multi-Year Partnership Renewal

Looking Into Hayward Holdings’s Return On Invested Capital

Pfizer, Valneva’s Tick-Borne Infection Shot: Companies Say ‘Positive’ Result For Lyme Disease Vaccine Candidate Booster